Impairment of pancreatic β-cell function by chronic intermittent hypoxia

Experimental Physiology

Volumn 98, Issue 9, 2013, Pages 1376-1385

  Wang, Ning ^a   Khan, Shakil A ^a   Prabhakar, Nanduri R ^a   Nanduri, Jayasri ^a  

^a University of Chicago   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FURIN; GLUCAGON; GLUCOSE; INSULIN; MESSENGER RNA; PROINSULIN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APNEA; ARTICLE; BREATHING DISORDER; CELL PROLIFERATION; CELL STRUCTURE; CHRONIC INTERMITTENT HYPOXIA; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; IN VITRO STUDY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; MITOCHONDRION; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET DISEASE; PROTEIN EXPRESSION;

EID: 84882590140     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2013.072454     Document Type: Article

References (32)

1. Asghar Z, Yau D, Chan F, Leroith D, Chan CB & Wheeler MB (2006). Insulin resistance causes increased beta cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes. Diabetologia 49, 90-99.
2. Bollheimer LC, Skelly RH, Chester MW, McGarry JD & Rhodes CJ (1998). Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J Clin Invest 101, 1094-1101.
3. Devasagayam TP, Boloor KK & Ramasarma T (2003). Methods for estimating lipid peroxidation: an analysis of merits and demerits. Indian J Biochem Biophys 40, 300-308.
4. Fridlyand LE & Philipson LH (2006). Reactive species, cellular repair and risk factors in the onset of type 2 diabetes mellitus: review and hypothesis. Curr Diabetes Rev 2, 241-259.
5. Idris I, Hall AP, O'Reilly J, Barnett A, Allen M, Andrews R, Grunstein P, Lewis K, Goenka N & Wilding JP (2009). Obstructive sleep apnoea in patients with type 2 diabetes: aetiology and implications for clinical care. Diabetes Obes Metab 11, 733-741.
6. Jacobson DA, Kuznetsov A, Lopez JP, Kash S, Ammälä CE & Philipson LH (2007). Kv2.1 ablation alters glucose-induced islet electrical activity, enhancing insulin secretion. Cell Metab 6, 229-235.
7. Khan SA, Nanduri J, Yuan G, Kinsman B, Kumar GK, Joseph J, Kalyanaraman B & Prabhakar NR (2011). NADPH oxidase 2 mediates intermittent hypoxia-induced mitochondrial complex I inhibition: relevance to blood pressure changes in rats. Antioxid Redox Signal 14, 533-542.
8. Laaban JP, Daenen S, Léger D, Pascal S, Bayon V, Slama G & Elgrably F (2009). Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients. Diabetes Metab 35, 372-377.
9. Lai JC & Clark JB (1979). Preparation of synaptic and nonsynaptic mitochondria from mammalian brain. Methods Enzymol 55, 51-60.
10. Lavie L (2009). Oxidative stress-a unifying paradigm in obstructive sleep apnea and comorbidities. Prog Cardiovasc Dis 51, 303-312.
11. Lenzen S, Drinkgern J & Tiedge M (1996). Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 20, 463-466.
12. Marshall NS, Wong KK, Liu PY, Cullen SR, Knuiman MW & Grunstein RR (2008). Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 31, 1079-1085.
13. Morgan D, Rebelato E, Abdulkader F, Graciano MF, Oliveira-Emilio HR, Hirata AE, Rocha MS, Bordin S, Curi R & Carpinelli AR (2009). Association of NAD(P)H oxidase with glucose-induced insulin secretion by pancreatic β-cells. Endocrinology 150, 2197-2201.
14. Nanduri J, Wang N, Yuan G, Khan SA, Souvannakitti D, Peng YJ, Kumar GK, Garcia JA & Prabhakar NR (2009). Intermittent hypoxia degrades HIF-2α via calpains resulting in oxidative stress: implications for recurrent apnea-induced morbidities. Proc Natl Acad Sci U S A 106, 1199-1204.
15. Newsholme P, Haber EP, Hirabara SM, Rebelato EL, Procopio J, Morgan D, Oliveira-Emilio HC, Carpinelli AR & Curi R (2007). Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol 583, 9-24.
16. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz MD & Pickering TG (2000). Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283, 1829-1836.
17. O'Donnell CP (2007). Metabolic consequences of intermittent hypoxia. Adv Exp Med Biol 618, 41-49.
18. Pallayova M, Lazurova I & Donic V (2011). Hypoxic damage to pancreatic beta cells - the hidden link between sleep apnea and diabetes. Med Hypotheses 77, 930-934.
19. Peng YJ, Yuan G, Ramakrishnan D, Sharma SD, Bosch-Marce M, Kumar GK, Semenza GL, Prabhakar NR (2006). Heterozygous HIF-1 alpha deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol, 577, 705-716.
20. Prabhakar NR, Kumar GK, Nanduri J & Semenza GL (2007). ROS signaling in systemic and cellular responses to chronic intermittent hypoxia. Antioxid Redox Signal 9, 1397-1403.
21. Raghuraman G, Rai V, Peng YJ, Prabhakar NR & Kumar GK (2009). Pattern-specific sustained activation of tyrosine hydroxylase by intermittent hypoxia: role of reactive oxygen species-dependent downregulation of protein phosphatase 2A and upregulation of protein kinases. Antioxid Redox Signal 11, 1777-1789.
22. Rahangdale S, Yeh SY, Malhotra A & Veves A (2009). Therapeutic interventions and oxidative stress in diabetes. Front Biosci 14, 192-209.
23. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, O'Connor GT, Boland LL, Schwartz JE & Samet JM (2001). Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163, 19-25.
24. Sivitz WI & Yorek MA (2010). Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid Redox Signal 12, 537-577.
25. Tasali E, Mokhlesi B & Van Cauter E (2008). Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 133, 496-506.
26. Tiedge M, Lortz S, Drinkgern J & Lenzen S (1997). Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46, 1733-1742.
27. Trnka J, Blaikie FH, Logan A, Smith RA & Murphy MP (2009). Antioxidant properties of MitoTEMPOL and its hydroxylamine. Free Radic Res 43, 4-12.
28. Wang J, Chen Y, Yuan Q, Tang W, Zhang X & Osei K (2011). Control of precursor maturation and disposal is an early regulative mechanism in the normal insulin production of pancreatic β-cells. PLoS One 6, e19446.
29. Wang J & Osei K (2011). Proinsulin maturation disorder is a contributor to the defect of subsequent conversion to insulin in β-cells. Biochem Biophys Res Commun 411, 150-155.
30. Xu J, Long YS, Gozal D & Epstein PN (2009). β-Cell death and proliferation after intermittent hypoxia: role of oxidative stress. Free Radic Biol Med 46, 783-790.
31. Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Nieto FJ, Stubbs R & Hla KM (2008). Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 31, 1071-1078.
32. Yuan G, Adhikary G, McCormick AA, Holcroft JJ, Kumar GK & Prabhakar NR (2004). Role of oxidative stress in intermittent hypoxia-induced immediate early gene activation in rat PC12 cells. J Physiol 557, 773-783.